Moderator
Fei-Yuan Sharon Hsiao, PhD, College of Medicine, National Taiwan University, Taipei, Taiwan
Speakers
Mahendra Kumar Rai, PhD, EVERSANA, Singapore, Singapore; Sallie Pearson, PhD, The University of New South Wales, Sydney, Australia; Bor-Sheng Ko, PhD, MD, National Taiwan University Hospital, New Taipei City, Taiwan; Boxiong Tang, PhD, MD, TZ Health, Collegeville, PA, United States; Yoshiaki Uyama, PhD, Pharmaceuticals & Medical Devices Agency (PMDA), Tokyo, Japan
This plenary session examines the evolving landscape of Real-World Evidence (RWE) across the Asia Pacific region, where adoption varies significantly between countries despite growing interest. Speakers will explore how RWD/RWE is increasingly supporting decision-making in life sciences, regulatory approvals, and reimbursement. The session will highlight regional efforts while addressing critical challenges including data availability, data quality, interoperability, privacy concerns, and potential biases. Attendees will gain insights into how RWE can play a role in decision-making process and discover practical lessons for infrastructure development and capacity building specific to Asia Pacific healthcare environments.
Code
05b